abstract |
The present invention relates to a 5-phenylbenzylaminencompound represented by the formula [1]:n nwherein Ring A represents a phenyl group having ansubstituent(s), n R a , R b1 and R b2 each represent hydrogen atom, anhalogen atom, a lower alkyl group, a halogeno-lowernalkyl group or a lower alkoxy group, n R c1 represents hydrogen atom, a lower alkyl groupnoptionally substituted by a heterocyclic group, or annacyl group, n R c2 and R e each represent hydrogen atom or a lowernalkyl group, n R d represents hydrogen atom, a lower alkyl group ornan acyl group, and n R f represents a lower alkyl group or a cyclic lowernalkyl group, nor a pharmaceutically acceptable salt thereof, a processnfor preparing the same and synthetic intermediate thereof. |